EMILY DYE: Open Payments
NPI 1073106332 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 19 payments from 8 companies in 2025. Trend: 2023 $99 · 2024 $81 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 8 | $206 |
| GlaxoSmithKline, LLC. | 4 | $93 |
| Galderma Laboratories, L.P. | 1 | $80 |
| AERIN MEDICAL INC. | 1 | $67 |
| Optinose US, Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
Products named: NEFFY, NUCALA, VIVAER STYLUS, Xhance, DUPIXENT, Ryaltris, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
